IO Biotech, Inc. (IOBT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -18.48M | -19.82M | -23.07M | -19.63M | -20.81M | -16.98M | -24.93M | -22.8M | -15.99M | -18.26M | -14.69M | -12.53M | -13.35M | -13.01M | -20.84M | -19.24M | -8.17M | -9.4M | -3.89M | -3.09M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 11.2% | -16.72% | 7.46% | 13.91% | -30.13% | 7.01% | -69.72% | -81.98% | -19.79% | -40.36% | 29.52% | 34.9% | -63.36% | -38.4% | -435.56% | -521.85% | - | - | -165517.02% | - |
| Net Income | -8.38M | -26.22M | -22.42M | -31.33M | -24.02M | -20.69M | -19.46M | -26.18M | -21.68M | -21.18M | -17.04M | -20.07M | -15.69M | -18.5M | -17.2M | -21.31M | -4.46M | -41.73M | -3.75M | -2.55M |
| Depreciation & Amortization | 230K | 234K | 227K | 219K | 205K | 214K | 211K | 201K | 194K | 187K | 174K | 190K | 119K | 11K | 220K | 0 | -1K | 1K | 0 | 0 |
| Stock-Based Compensation | 1.48M | 1.61M | 1.57M | 1.63M | 1.68M | 1.64M | 1.57M | 1.56M | 2.99M | 1.62M | 1.89M | 1.66M | 2.4M | 1.36M | 1.62M | 1.3M | 483K | 5K | 4K | 16K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -9.06M | 3.21M | 105K | 4.67M | -1.63M | 1.27M | 462K | -405K | 342K | -10K | -258K | -435K | 87K | 285K | 20K | -305K | -2.65M | 29.29M | -137K | 7K |
| Working Capital Changes | -2.75M | 1.34M | -2.55M | 5.19M | 2.95M | 580K | -7.71M | 2.03M | 2.16M | 1.11M | 550K | 6.13M | -267K | 3.83M | -5.5M | 1.07M | -1.54M | 3.04M | -11K | -563K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 50K | 339K | 538K | -596K | 239K | 1.18M | -38K | -2.77M | 2.18M | 204K | 256K | 1.84M | -2.37M | 2.45M | -1.84M | 1.76M | 470K | 496K | 678K | -434K |
| Cash from Investing | -4K | -26K | -28K | -11K | -10K | -12K | -11K | -112K | -24K | -39K | -148K | -349K | -118K | -107K | -116K | -150K | -3K | 0 | 0 | 0 |
| Capital Expenditures | -4K | -26K | -28K | -11K | -10K | -12K | -11K | -112K | -24K | -39K | -148K | -349K | -118K | -107K | -116K | -150K | -3K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 21.27M | 11.49M | 0 | 0 | 0 | 0 | 0 | -10K | 71.87M | 0 | 0 | 0 | 0 | 0 | 0 | 187.54M | 0 | 0 | 65.41M | 0 |
| Debt Issued (Net) | 14.7M | 11.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 6.57M | 0 | 0 | 0 | 0 | 0 | 0 | -10K | 71.87M | 0 | 0 | 0 | 0 | 0 | 0 | 187.54M | 0 | 0 | 65.75M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -340K | 0 |
| Net Change in Cash | 2.53M | -8.96M | -22.95M | -20.15M | -20.56M | -17.23M | -25.21M | -22.31M | 55.41M | -18.43M | -14.06M | -8.58M | -18.95M | -17.78M | -23.63M | 166.05M | -9.28M | -8.47M | 59.82M | -2.91M |
| Free Cash Flow | -18.48M | -19.85M | -23.1M | -19.64M | -20.82M | -16.99M | -24.94M | -22.91M | -16.01M | -18.3M | -14.84M | -12.88M | -13.47M | -13.12M | -20.96M | -19.39M | -8.17M | -9.4M | -3.89M | -3.09M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 11.22% | -16.79% | 7.39% | 14.28% | -30% | 7.14% | -68.1% | -77.92% | -18.92% | -39.51% | 29.21% | 33.6% | -64.74% | -39.54% | -438.54% | -526.7% | - | - | -165517.02% | - |
| FCF per Share | -0.28 | -0.30 | -0.35 | -0.30 | -0.32 | -0.26 | -0.38 | -0.35 | -0.32 | -0.64 | -0.51 | -0.45 | -0.47 | -0.46 | -0.73 | -0.75 | -0.32 | -0.81 | -0.34 | -0.27 |
| FCF Conversion (FCF/Net Income) | 2.21x | 0.76x | 1.03x | 0.63x | 0.87x | 0.82x | 1.28x | 0.87x | 0.74x | 0.86x | 0.86x | 0.62x | 0.85x | 0.70x | 1.21x | 0.90x | 1.83x | 0.25x | 1.04x | 1.21x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |